MML Investors Services’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.07M Sell
24,957
-1,285
-5% -$107K 0.01% 1229
2025
Q1
$2.13M Sell
26,242
-27,028
-51% -$2.19M 0.01% 1144
2024
Q4
$4.8M Sell
53,270
-47
-0.1% -$4.23K 0.02% 729
2024
Q3
$5.27M Sell
53,317
-1,808
-3% -$179K 0.02% 657
2024
Q2
$5.11M Buy
55,125
+297
+0.5% +$27.5K 0.02% 624
2024
Q1
$5.2M Sell
54,828
-3,886
-7% -$369K 0.02% 623
2023
Q4
$5.24M Sell
58,714
-86,710
-60% -$7.74M 0.02% 576
2023
Q3
$10.6M Buy
145,424
+6,528
+5% +$477K 0.06% 319
2023
Q2
$11.6M Sell
138,896
-3,928
-3% -$327K 0.06% 295
2023
Q1
$10.9M Buy
142,824
+27,101
+23% +$2.07M 0.08% 263
2022
Q4
$9.61M Buy
115,723
+31,387
+37% +$2.61M 0.06% 312
2022
Q3
$6.69M Buy
84,336
+4,544
+6% +$360K 0.05% 353
2022
Q2
$5.93M Sell
79,792
-10,392
-12% -$772K 0.05% 374
2022
Q1
$8.11M Sell
90,184
-24,384
-21% -$2.19M 0.06% 321
2021
Q4
$12.8M Buy
114,568
+18,292
+19% +$2.05M 0.09% 229
2021
Q3
$12.1M Buy
96,276
+11,398
+13% +$1.43M 0.1% 233
2021
Q2
$11.5M Buy
84,878
+21,921
+35% +$2.97M 0.1% 229
2021
Q1
$8.54M Buy
62,957
+15,307
+32% +$2.08M 0.08% 250
2020
Q4
$6.71M Sell
47,650
-11,156
-19% -$1.57M 0.07% 262
2020
Q3
$6.55M Sell
58,806
-5,119
-8% -$570K 0.08% 230
2020
Q2
$7.16M Sell
63,925
-4,904
-7% -$549K 0.1% 217
2020
Q1
$5.33M Buy
68,829
+7,723
+13% +$598K 0.09% 221
2019
Q4
$5.81M Sell
61,106
-35,497
-37% -$3.38M 0.08% 238
2019
Q3
$7.37M Buy
96,603
+11,726
+14% +$894K 0.12% 191
2019
Q2
$7.45M Buy
84,877
+20,445
+32% +$1.79M 0.11% 210
2019
Q1
$5.83M Buy
64,432
+3,261
+5% +$295K 0.09% 229
2018
Q4
$4.39M Buy
61,171
+14,466
+31% +$1.04M 0.08% 260
2018
Q3
$4.48M Buy
46,705
+6,135
+15% +$588K 0.08% 251
2018
Q2
$3.86M Buy
40,570
+2,499
+7% +$238K 0.08% 232
2018
Q1
$3.34M Buy
38,071
+1,517
+4% +$133K 0.07% 249
2017
Q4
$3.1M Buy
36,554
+12,803
+54% +$1.09M 0.06% 256
2017
Q3
$2.06M Buy
23,751
+1,168
+5% +$101K 0.04% 326
2017
Q2
$1.74M Buy
+22,583
New +$1.74M 0.03% 356